NCT00183794 - Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2010

Conditions

Ovarian CarcinomaPeritoneal Neoplasms

Interventions

DRUG

Docetaxel and Gemcitabine

Docetaxel 75 mg/m2 IV over 15-30 minutes on day 1 followed by Gemcitabine 800 mg/m2 IV over 30 minutes on Days 1 and 8 of each 3 weeks (21 days) cycle.

Trial Locations (1)

90033

Norris Comprehensive Cancer Center, Los Angeles